Treatments of disease relapse after allogeneic stem cell transplantation focusing on donor lymphocyte infusion

二维码有效期 120s

摘要Hematopoietic stem cell transplantation (SCT) is a potentially curative treatment for patients with hematologic malignancies,such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).There has been tremendous progress in the past several decades in allogeneic SCT with better outcomes through improvements in supportive care,expansion of stem cell donor options (HLA-matched unrelated donors (MUD),haploidentical related donors,and cord blood units (CBUs)etc.),and introduction of better tolerated reduced intensity conditioning (RIC) regimens.

作者单位 Section of Hematology/Oncology, University of Chicago, Chicago,IL, USA ^[1] Institute of Hematology, Peking University People's Hospital, Beijing 100044, China ^[2]

关键词 donor lymphocyte infusion acute myeloid leukemia allogeneic stem cell transplantation graft versus leukemia effect graft versus host disease

栏目名称 PERSPECTIVE

DOI 10.3760/cma.j.issn.0366-6999.20130572

发布时间 2014-01-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交